Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 23;11(4):573.
doi: 10.3390/cancers11040573.

Dysregulation of Natural Killer Cells in Obesity

Affiliations
Review

Dysregulation of Natural Killer Cells in Obesity

Donal O'Shea et al. Cancers (Basel). .

Abstract

Natural killer (NK) cells are a population of lymphocytes which classically form part of the innate immune system. They are defined as innate lymphocytes, due to their ability to kill infected or transformed cells without prior activation. In addition to their cytotoxic abilities, NK cells are also rapid producers of inflammatory cytokines such as interferon gamma (IFN-γ) and are therefore a critical component of early immune responses. Due to these unique abilities, NK cells are a very important component of host protection, especially anti-tumour and anti-viral immunity. Obesity is a worldwide epidemic, with over 600 million adults and 124 million children now classified as obese. It is well established that individuals who are obese are at a higher risk of many acute and chronic conditions, including cancer and viral infections. Over the past 10 years, many studies have investigated the impact of obesity on NK cell biology, detailing systemic dysregulation of NK cell functions. More recently, several studies have investigated the role of NK cells in the homeostasis of adipose tissue and the pathophysiology of obesity. In this review, we will discuss in detail these studies and focus on emerging data detailing the metabolic mechanisms altering NK cells in obesity.

Keywords: NK cell; adipose tissue; cancer; metabolism; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of NK cell phenotype in health and obesity (A) schematic detailing human NK cell phenotype; surface molecules (CD56, CD16, natural killer group (NKG)2 family and killer-cell immunoglobulin-like receptors (KIRs), cytokine receptors (Interleukin(IL)-2, IL-12, IL-15 and IL-18) and effector molecules (cytokine and lytic molecule) production; (B) schematic detailing the impact of obesity on NK cells (lower cell frequencies, reduced cytokine production and reduced cytotoxicity); (C) schematic detailing the impact of weight loss on NK cells (restored frequencies, effector molecule production and cytotoxicity).
Figure 2
Figure 2
Overview of obesity induced changes in NK cell metabolism and function (A) in healthy individuals upon activation, NK cells increase their glycolytic metabolism mediated by mammalian target of rapamycin (mTOR), resulting in interferon (IFN)-γ production and tumor cell lysis; (B) in obese individuals, NK cells increase their expression of lipid uptake receptors (CD36, LDLR) resulting in increased uptake of free fatty acids. Upon activation, NK cells fail to activate mTOR and glycolytic metabolism resulting in decreased IFN-γ production, altered polarization of degranulation and defective tumor cell lysis.

Similar articles

Cited by

References

    1. NCD Risk Factor Collaboration Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387:1377–1396. doi: 10.1016/S0140-6736(16)30054-X. - DOI - PMC - PubMed
    1. NCD Risk Factor Collaboration Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–2642. doi: 10.1016/S0140-6736(17)32129-3. - DOI - PMC - PubMed
    1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., Mullany E.C., Biryukov S., Abbafati C., Abera S.F., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–781. doi: 10.1016/S0140-6736(14)60460-8. - DOI - PMC - PubMed
    1. Juonala M., Magnussen C.G., Berenson G.S., Venn A., Burns T.L., Sabin M.A., Srinivasan S.R., Daniels S.R., Davis P.H., Chen W., et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N. Engl. J. Med. 2011;365:1876–1885. doi: 10.1056/NEJMoa1010112. - DOI - PubMed
    1. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88. - DOI - PMC - PubMed

LinkOut - more resources